• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于黏蛋白表达水平的胆管癌风险评估模型的建立

Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels.

作者信息

Yang Chun-Yuan, Guo Li-Mei, Li Yang, Wang Guang-Xi, Tang Xiao-Wei, Zhang Qiu-Lu, Zhang Ling-Fu, Luo Jian-Yuan

机构信息

Department of Pathology, Institute of Systems Biomedicine, School of Basic Medical Sciences Peking University, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.

Department of General Surgery, Peking University Third Hospital, Beijing 100191, China.

出版信息

World J Gastrointest Oncol. 2024 Apr 15;16(4):1344-1360. doi: 10.4251/wjgo.v16.i4.1344.

DOI:10.4251/wjgo.v16.i4.1344
PMID:38660669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11037065/
Abstract

BACKGROUND

Cholangiocarcinoma (CCA) is a highly malignant cancer, characterized by frequent mucin overexpression. has been identified as a critical oncogene in the progression of CCA. However, the comprehensive understanding of how the mucin family influences CCA progression and prognosis is still incomplete.

AIM

To investigate the functions of mucins on the progression of CCA and to establish a risk evaluation formula for stratifying CCA patients.

METHODS

Single-cell RNA sequencing data from 14 CCA samples were employed for elucidating the roles of mucins, complemented by bioinformatic analyses. Subsequent validations were conducted through spatial transcriptomics and immunohistochemistry. The construction of a risk evaluation model utilized the least absolute shrinkage and selection operator regression algorithm, which was further confirmed by independent cohorts and diverse data types.

RESULTS

CCA tumor cells with elevated levels of and showed activated nucleotide metabolic pathways and increased invasiveness. -high cells were found to promote CCA progression through WNT signaling. -high cells exhibited robust cellular oxidation activities, leading to resistance against antitumoral treatments. -high cells were observed to secret chemokines, recruiting and transforming macrophages into the M2-polarized state, thereby suppressing antitumor immunity. -high cells were found to promote tumor progression through interleukin-1/nuclear factor kappa-light-chain-enhancer of activated B cells signaling upon interaction with neutrophils. Utilizing the expression levels of these mucins, a risk factor evaluation formula for CCA was developed and validated across multiple cohorts. CCA samples with higher risk factors exhibited stronger metastatic potential, chemotherapy resistance, and poorer prognosis.

CONCLUSION

Our study elucidates the functional mechanisms through which mucins contribute to CCA development, and provides tools for risk stratification in CCA.

摘要

背景

胆管癌(CCA)是一种高度恶性的癌症,其特征是粘蛋白频繁过表达。已被确定为CCA进展中的关键致癌基因。然而,对粘蛋白家族如何影响CCA进展和预后的全面理解仍不完整。

目的

研究粘蛋白在CCA进展中的作用,并建立一个用于对CCA患者进行分层的风险评估公式。

方法

使用来自14个CCA样本的单细胞RNA测序数据来阐明粘蛋白的作用,并辅以生物信息学分析。随后通过空间转录组学和免疫组织化学进行验证。风险评估模型的构建采用最小绝对收缩和选择算子回归算法,并通过独立队列和不同数据类型进一步确认。

结果

和水平升高的CCA肿瘤细胞显示出激活的核苷酸代谢途径和增加的侵袭性。发现高细胞通过WNT信号通路促进CCA进展。高细胞表现出强大的细胞氧化活性,导致对抗肿瘤治疗的抗性。观察到高细胞分泌趋化因子,将巨噬细胞募集并转化为M2极化状态,从而抑制抗肿瘤免疫。发现高细胞在与中性粒细胞相互作用时通过白细胞介素-1/活化B细胞核因子κ-轻链增强子信号通路促进肿瘤进展。利用这些粘蛋白的表达水平,开发了一个CCA风险因素评估公式,并在多个队列中进行了验证。具有较高风险因素的CCA样本表现出更强的转移潜力、化疗抗性和更差的预后。

结论

我们的研究阐明了粘蛋白促进CCA发展的功能机制,并为CCA的风险分层提供了工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/7ad40884d548/WJGO-16-1344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/9c18df0bf13d/WJGO-16-1344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/2b1004ae6fb2/WJGO-16-1344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/23a52aa1b7ab/WJGO-16-1344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/7e3433e6f177/WJGO-16-1344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/a0cec96d55f5/WJGO-16-1344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/a9ec3ba25f82/WJGO-16-1344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/7ad40884d548/WJGO-16-1344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/9c18df0bf13d/WJGO-16-1344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/2b1004ae6fb2/WJGO-16-1344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/23a52aa1b7ab/WJGO-16-1344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/7e3433e6f177/WJGO-16-1344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/a0cec96d55f5/WJGO-16-1344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/a9ec3ba25f82/WJGO-16-1344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3f/11037065/7ad40884d548/WJGO-16-1344-g007.jpg

相似文献

1
Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels.基于黏蛋白表达水平的胆管癌风险评估模型的建立
World J Gastrointest Oncol. 2024 Apr 15;16(4):1344-1360. doi: 10.4251/wjgo.v16.i4.1344.
2
Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.涎腺黏液表皮样癌中膜结合黏蛋白(MUC1和MUC4)及分泌性黏蛋白(MUC2、MUC5AC、MUC5B、MUC6和MUC7)的表达
Am J Surg Pathol. 2005 Jun;29(6):806-13. doi: 10.1097/01.pas.0000155856.84553.c9.
3
Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.泰国患者胆管癌组织中粘蛋白6糖蛋白表达增强作为生存预后标志物
J Gastroenterol Hepatol. 2008 May;23(5):771-8. doi: 10.1111/j.1440-1746.2008.05332.x.
4
Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis.黏蛋白:在肝胆癌发生中的“旧将”、“新丁”与潜力因子。
Int J Mol Sci. 2019 Mar 14;20(6):1288. doi: 10.3390/ijms20061288.
5
GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.GATA6 通过 MUC1/β-连环蛋白通路促进胆管癌的上皮-间充质转化和转移。
Cell Death Dis. 2020 Oct 15;11(10):860. doi: 10.1038/s41419-020-03070-z.
6
Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.跨膜黏蛋白MUC1、MUC4和MUC16在正常子宫内膜及子宫内膜异位症中的表达
Hum Reprod. 2014 Aug;29(8):1730-8. doi: 10.1093/humrep/deu146. Epub 2014 Jun 17.
7
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).MUC4在卵巢癌中的异常表达:单独及与MUC1和MUC16(CA125)联合的诊断意义
Mod Pathol. 2006 Oct;19(10):1386-94. doi: 10.1038/modpathol.3800646. Epub 2006 Jul 28.
8
Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.黏蛋白 4 通过激活 AKT 赋予胆管癌患者吉西他滨耐药性和不良预后。
Int J Biol Sci. 2023 May 21;19(9):2772-2786. doi: 10.7150/ijbs.79126. eCollection 2023.
9
Macrophages-aPKC-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma.巨噬细胞-aPKC-CCL5 反馈环调节胆管癌的进展和化疗耐药性。
J Exp Clin Cancer Res. 2022 Jan 15;41(1):23. doi: 10.1186/s13046-021-02235-8.
10
Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers.黏蛋白糖蛋白通过多种途径在上皮性癌中阻断细胞凋亡;促进侵袭、增殖和迁移;并导致化疗耐药。
Cancer Metastasis Rev. 2019 Jun;38(1-2):237-257. doi: 10.1007/s10555-019-09781-w.

本文引用的文献

1
Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma.针对 MUC1 肿瘤相关糖型的工程化 CAR T 细胞的开发用于治疗肝内胆管癌。
J Immunother. 2023 Apr 1;46(3):89-95. doi: 10.1097/CJI.0000000000000460. Epub 2023 Mar 8.
2
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.肝肿瘤免疫微环境亚型与中性粒细胞异质性
Nature. 2022 Dec;612(7938):141-147. doi: 10.1038/s41586-022-05400-x. Epub 2022 Nov 9.
3
Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance.
白细胞介素-1 和核因子-κB 信号促进乳腺癌的进展和治疗耐药性。
Cells. 2022 May 18;11(10):1673. doi: 10.3390/cells11101673.
4
Metabolic reprogramming in cholangiocarcinoma.胆管癌中的代谢重编程。
J Hepatol. 2022 Sep;77(3):849-864. doi: 10.1016/j.jhep.2022.04.038. Epub 2022 May 18.
5
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma.单细胞转录组分析提示肝内胆管癌存在两种分子亚型。
Nat Commun. 2022 Mar 28;13(1):1642. doi: 10.1038/s41467-022-29164-0.
6
Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression.肝内胆管癌起始和进展过程中的细胞异质性和转录组图谱。
Hepatology. 2022 Nov;76(5):1302-1317. doi: 10.1002/hep.32483. Epub 2022 Apr 24.
7
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.蛋白质基因组学特征鉴定出肝内胆管癌的临床相关亚组。
Cancer Cell. 2022 Jan 10;40(1):70-87.e15. doi: 10.1016/j.ccell.2021.12.006. Epub 2021 Dec 30.
8
Comprehensive analysis of spatial architecture in primary liver cancer.原发性肝癌空间结构的综合分析
Sci Adv. 2021 Dec 17;7(51):eabg3750. doi: 10.1126/sciadv.abg3750.
9
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.多种癌症相关成纤维细胞亚群促进胆管癌生长。
Cancer Cell. 2021 Jun 14;39(6):866-882.e11. doi: 10.1016/j.ccell.2021.03.012. Epub 2021 Apr 29.
10
FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program.FOSL1 通过超级增强子驱动的转录程序促进头颈部鳞状细胞癌的转移。
Mol Ther. 2021 Aug 4;29(8):2583-2600. doi: 10.1016/j.ymthe.2021.03.024. Epub 2021 Mar 29.